(MRCY) Mercury Systems - Ratings and Ratios
Embedded, Avionics, Radar, Subsystems, Components
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 43.2% |
| Value at Risk 5%th | 62.3% |
| Relative Tail Risk | -12.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.84 |
| Alpha | 119.29 |
| CAGR/Max DD | 0.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.529 |
| Beta | 0.797 |
| Beta Downside | 0.533 |
| Drawdowns 3y | |
|---|---|
| Max DD | 53.32% |
| Mean DD | 26.26% |
| Median DD | 28.77% |
Description: MRCY Mercury Systems January 12, 2026
Mercury Systems, Inc. (NASDAQ:MRCY) designs, manufactures, and integrates high-performance electronic components, modules, and subsystems for defense prime contractors, OEMs, government agencies, and commercial aerospace customers. Its product portfolio spans RF power amplifiers, microwave integrated circuits, digital-analog converters, embedded processing boards, and specialized radar-simulation and electronic-warfare systems for UAVs and other platforms.
Operating across the United States, Europe, and the Asia-Pacific, Mercury leverages a vertically integrated model that combines in-house silicon design with assembly and test, enabling tighter control of bill-of-materials costs and faster time-to-market for classified programs.
Key recent metrics (FY 2023): revenue of $1.48 billion, a 9 % YoY increase, operating margin of 12 %, and a backlog of roughly $2.2 billion-indicating strong demand pipeline. R&D intensity remains high at ~13 % of revenue, reflecting the firm’s focus on next-gen RF and AI-enabled signal-processing capabilities.
Sector drivers that materially affect MRCY include the U.S. defense budget outlook (projected FY 2025 discretionary defense spending to rise ~3 % YoY) and the accelerating adoption of autonomous UAVs, which fuels demand for compact, high-throughput signal-processing and electronic-warfare payloads.
For a deeper quantitative view of MRCY’s valuation metrics, the ValueRay platform offers a concise, data-driven dashboard.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -68.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.59 > 1.0 |
| NWC/Revenue: 87.53% < 20% (prev 79.64%; Δ 7.89% < -1%) |
| CFO/TA 0.07 > 3% & CFO 183.5m > Net Income -68.4m |
| Net Debt (340.4m) to EBITDA (25.6m): 13.29 < 3 |
| Current Ratio: 3.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (59.2m) vs 12m ago 1.60% < -2% |
| Gross Margin: 27.32% > 18% (prev 0.28%; Δ 2704 % > 0.5%) |
| Asset Turnover: 36.09% > 50% (prev 38.24%; Δ -2.15% > 0%) |
| Interest Coverage Ratio: -1.78 > 6 (EBITDA TTM 25.6m / Interest Expense TTM 30.4m) |
Altman Z'' 2.29
| A: 0.31 (Total Current Assets 1.08b - Total Current Liabilities 322.2m) / Total Assets 2.46b |
| B: 0.07 (Retained Earnings 169.4m / Total Assets 2.46b) |
| C: -0.02 (EBIT TTM -54.1m / Avg Total Assets 2.41b) |
| D: 0.18 (Book Value of Equity 173.6m / Total Liabilities 982.6m) |
| Altman-Z'' Score: 2.29 = BBB |
Beneish M -3.27
| DSRI: 0.90 (Receivables 367.5m/422.8m, Revenue 871.0m/906.0m) |
| GMI: 1.01 (GM 27.32% / 27.59%) |
| AQI: 0.94 (AQ_t 0.49 / AQ_t-1 0.53) |
| SGI: 0.96 (Revenue 871.0m / 906.0m) |
| TATA: -0.10 (NI -68.4m - CFO 183.5m) / TA 2.46b) |
| Beneish M-Score: -3.27 = AA |
ValueRay F-Score (Strict, 0-100) 36.31
| 1. Piotroski: 3.50pt |
| 2. FCF Yield: 2.66% |
| 3. FCF Margin: 18.83% |
| 4. Debt/Equity: 0.44 |
| 5. Debt/Ebitda: 13.29 |
| 6. ROIC - WACC: -10.12% |
| 7. RoE: -4.68% |
| 8. Revenue Trend: -42.17% |
| 9. EPS Trend: -33.81% |
What is the price of MRCY shares?
Over the past week, the price has changed by -3.85%, over one month by +31.94%, over three months by +27.64% and over the past year by +133.28%.
Is MRCY a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 3
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the MRCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 90.9 | -8.2% |
| Analysts Target Price | 90.9 | -8.2% |
| ValueRay Target Price | 102.7 | 3.7% |
MRCY Fundamental Data Overview January 22, 2026
P/S = 6.2561
P/B = 4.1976
P/EG = 2.651
Revenue TTM = 871.0m USD
EBIT TTM = -54.1m USD
EBITDA TTM = 25.6m USD
Long Term Debt = 591.5m USD (from longTermDebt, last quarter)
Short Term Debt = 11.8m USD (from shortTermDebt, two quarters ago)
Debt = 645.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 340.4m USD (from netDebt column, last quarter)
Enterprise Value = 6.18b USD (5.84b + Debt 645.1m - CCE 304.7m)
Interest Coverage Ratio = -1.78 (Ebit TTM -54.1m / Interest Expense TTM 30.4m)
EV/FCF = 37.66x (Enterprise Value 6.18b / FCF TTM 164.0m)
FCF Yield = 2.66% (FCF TTM 164.0m / Enterprise Value 6.18b)
FCF Margin = 18.83% (FCF TTM 164.0m / Revenue TTM 871.0m)
Net Margin = -7.86% (Net Income TTM -68.4m / Revenue TTM 871.0m)
Gross Margin = 27.32% ((Revenue TTM 871.0m - Cost of Revenue TTM 633.1m) / Revenue TTM)
Gross Margin QoQ = 27.93% (prev 27.02%)
Tobins Q-Ratio = 2.51 (Enterprise Value 6.18b / Total Assets 2.46b)
Interest Expense / Debt = 0.91% (Interest Expense 5.86m / Debt 645.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -42.7m (EBIT -54.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.37 (Total Current Assets 1.08b / Total Current Liabilities 322.2m)
Debt / Equity = 0.44 (Debt 645.1m / totalStockholderEquity, last quarter 1.48b)
Debt / EBITDA = 13.29 (Net Debt 340.4m / EBITDA 25.6m)
Debt / FCF = 2.08 (Net Debt 340.4m / FCF TTM 164.0m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.84% (Net Income -68.4m / Total Assets 2.46b)
RoE = -4.68% (Net Income TTM -68.4m / Total Stockholder Equity 1.46b)
RoCE = -2.63% (EBIT -54.1m / Capital Employed (Equity 1.46b + L.T.Debt 591.5m))
RoIC = -2.08% (negative operating profit) (NOPAT -42.7m / Invested Capital 2.06b)
WACC = 8.04% (E(5.84b)/V(6.48b) * Re(8.85%) + D(645.1m)/V(6.48b) * Rd(0.91%) * (1-Tc(0.21)))
Discount Rate = 8.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.30%
[DCF Debug] Terminal Value 70.04% ; FCFF base≈137.1m ; Y1≈90.0m ; Y5≈41.1m
Fair Price DCF = 7.60 (EV 797.1m - Net Debt 340.4m = Equity 456.7m / Shares 60.1m; r=8.04% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -33.81 | EPS CAGR: -19.71% | SUE: -0.29 | # QB: 0
Revenue Correlation: -42.17 | Revenue CAGR: 0.58% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.23 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=9
EPS current Year (2026-06-30): EPS=1.02 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+58.9% | Growth Revenue=+4.4%
EPS next Year (2027-06-30): EPS=1.51 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=+48.3% | Growth Revenue=+9.0%
Additional Sources for MRCY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle